About LIMAA Technologies
LIMAA Technologies is a company based in Berlin (Germany) founded in 2022 by Rene Hagerling and Fabian Mohr. LIMAA Technologies offers products and services including Histopathology Platform, Reagents for Staining, and Light-Sheet Microscopy Hardware. LIMAA Technologies operates in a competitive market with competitors including PathAI, Deepcell, Aignostics, Pictor Labs and Neko Health, among others.
- Headquarter Berlin, Germany
- Founders Rene Hagerling, Fabian Mohr
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Limaa Technologies Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LIMAA Technologies
LIMAA Technologies offers a comprehensive portfolio of products and services, including Histopathology Platform, Reagents for Staining, and Light-Sheet Microscopy Hardware.
Fully automated system for tissue preparation and 3D scanning in pathology.
Standardized solutions for swift histochemical and immuno-stainings.
Technology for rapid tissue visualization and digitization.
Funding Insights of LIMAA Technologies
Investors in LIMAA Technologies
LIMAA Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Freie Universitat Berlin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
University offering multiple courses and degrees across diversified streams
|
Locked | Locked | Locked |
Investor details for LIMAA Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LIMAA Technologies
Investment portfolio details for LIMAA Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LIMAA Technologies
Detailed financials for LIMAA Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Limaa Technologies Comparisons
Peer comparison for LIMAA Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LIMAA Technologies
LIMAA Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Deepcell, Aignostics, Pictor Labs and Neko Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
|
| Locked | Locked | Locked |
Platform offering solutions for preventive health scans
|
|
| Locked | Locked | Locked |
Imaging systems and AI software for microscopes are developed.
|
Detailed competitors of LIMAA Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Limaa Technologies
Complete news archive for LIMAA Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LIMAA Technologies
LIMAA Technologies was founded in 2022.
LIMAA Technologies is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Fabian Mohr is the current CEO of LIMAA Technologies. They have also founded this company.
LIMAA Technologies was founded in 2022 in Berlin, Germany, within the histopathology sector. An issue-preserving platform is developed to enable 3D analysis of entire tissue biospecimens. Multiplex biomarker visualization is integrated for comprehensive imaging of whole samples. Operations focus on advancing tissue analysis techniques through this specialized technology, supporting medical research and diagnostics in Europe.
LIMAA Technologies's top competitors include Aignostics, Pictor Labs and PathAI.
LIMAA Technologies offers Histopathology Platform, Reagents for Staining, and Light-Sheet Microscopy Hardware.
LIMAA Technologies has 1 investor. Key investors include Freie Universitat Berlin.